Adalimumab in psoriatic arthritis: 24-week results of a phase III study

被引：0
作者：
Mease, P
Gladman, D
Ritchlin, C
Weinberg, M
机构：
[1] Univ Washington, Sch Med, Seattle, WA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Rochester, Rochester, NY USA
[4] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P2 / P2
页数：1
相关论文
共 50 条
  • [41] Remission of psoriatic arthritis 24 h after adalimumab therapy
    Song, Shaohui
    Wan, Li
    Xia, Ping
    Chen, Jinbo
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (11)
  • [42] Ultrasound Demonstrates Continued Improvement in Psoriatic Arthritis Synovitis and Enthesitis with Secukinumab: 52-week Results from a Phase III Study
    D'Agostino, Maria Antonietta
    Schett, Georg
    Gaillez, Corine
    Guerrero, Carlos
    Hanova, Petra
    Cazenave, Tomas
    Stoenoiu, Maria S.
    Backhaus, Marina
    Mouterde, Gael
    Boers, Maarten
    Duggan, Anne-Marie
    Goyanka, Punit
    Conaghan, Philip
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2839 - 2842
  • [43] A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
    Mease, Philip J.
    Smolen, Josef S.
    Behrens, Frank
    Nash, Peter
    Leage, Soyi Liu
    Li, Lingnan
    Tahir, Hasan
    Gooderham, Melinda
    Krishnan, Eswar
    Liu-Seifert, Hong
    Emery, Paul
    Pillai, Sreekumar G.
    Helliwell, Philip S.
    Naftal, Leonardo
    Hidalgo, Rodolfo Ariel Pardo
    Kerzberg, Eduardo Mario
    Savio, Veronica Gabriela
    Lazaro, Alicia
    Velasco, Benito Jorge
    Verzero, Norma Beatriz
    Asnal, Cecilia Adma
    Mysler, Eduardo Fabian
    Berman, Alberto
    Ariel, Federico Javier
    Rischmueller, Maureen
    Zochling, Jane Margaret
    Bird, Paul A.
    Hall, Stephen
    Ostor, Andrew
    Romas, Evange
    Stummvoll, Georg
    Machold, Klaus
    Spellitz, Peter
    Hanusch, Ursula
    Vanden Berghe, Marc
    Leon, Marc
    Vanhoof, Johan Louis Magda
    Van den Bosch, Filip Eduard Jeanne
    De Vlam, Kurt Leo Francois
    Morin, Frederic
    Bessette, Louis
    Haaland, Derek A.
    Schlemmer, Annette Margrethe
    Kristensen, Lars Erik
    Jarvinen, Pentti
    Peltomaa, Ritva Liisa
    Pirila, Laura
    Vuotila, Jorma
    Lespessailles, Eric
    Goupille, Philippe
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (01) : 123 - 131
  • [44] Adalimumab in the treatment of psoriasis and psoriatic arthritis: Ongoing results
    Papoutsaki, M
    Bianchi, L
    Chimenti, MS
    Chimenti, S
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB199 - AB199
  • [45] SECONDARY EFFICACY RESULTS UP TO WEEK 24 FROM A PHASE III STUDY COMPARING SB5 (AN ADALIMUMAB BIOSIMIAR) WITH ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY
    Kay, J.
    Weinblatt, M.
    Keystone, E.
    Genovese, M. C.
    Baranauskaite, A.
    Cheong, S. Y.
    Ghil, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 231 - 231
  • [46] Adalimumab for long-term treatment of psoriatic arthritis - Forty-eight week data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial
    Gladman, Dafna D.
    Mease, Philip J.
    Ritchlin, Christopher T.
    Choy, Ernest H. S.
    Sharp, John T.
    Ory, Peter A.
    Perdok, Renee J.
    Sasso, Eric H.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (02): : 476 - 488
  • [47] BARICITINIB IN THE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS IN CHINA: 24-WEEK RESULTS OF POSTMARKETING SAFETY STUDY
    Wu, C. Y.
    Wang, Q.
    Shi, J.
    Zhang, X.
    Du, R.
    Gu, J.
    Liu, Q. H.
    Yu, J.
    Xu, J. W.
    Zhang, Y. J.
    Zhu, H.
    Li, M.
    Zeng, X.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1418 - 1418
  • [48] COMPARISON OF SECUKINUMAB VERSUS ADALIMUMAB EFFICACY ON SKIN OUTCOMES IN PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM THE EXCEED STUDY
    Gottlieb, Alice
    Behrens, Frank
    Nash, Peter
    Merola, Joseph F.
    Pellet, Pascale
    Pricop, Luminita
    McInnes, Iain
    [J]. RHEUMATOLOGY, 2021, 60
  • [49] COMPARISON OF SECUKINUMAB VERSUS ADALIMUMAB EFFICACY ON SKIN OUTCOMES IN PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM THE EXCEED STUDY
    Gottlieb, A. B.
    Behrens, F.
    Nash, P.
    Merola, J. F.
    Ding, K.
    Pellet, P.
    Pricop, L.
    Mcinnes, I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 759 - 760
  • [50] Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial
    Kavanaugh, Arthur
    Husni, M. Elaine
    Harrison, Diane D.
    Kim, Lilianne
    Lo, Kim Hung
    Noonan, Lenore
    Hsia, Elizabeth C.
    [J]. JOURNAL OF RHEUMATOLOGY, 2019, 46 (06) : 595 - 602
12345